Zenotech Laboratories

Zenotech Laboratories FCF Growth

The Year-over-Year Free Cash Flow Growth of Zenotech Laboratories (532039.BO) as of Nov 22, 2026 is -66.53 %. In the previous year, Year-over-Year Free Cash Flow Growth was -25.88 % — a change of 157.11% (lower).

FCF Growth

-66.53 %

YoY

157.11%

Last updated:

Year-over-Year Free Cash Flow Growth of Zenotech Laboratories is 2026 -66.53 % . Year-over-Year Free Cash Flow Growth of Zenotech Laboratories was 2025 -25.88 % . It decreases by 157.11% lower compared to the previous year.

The Zenotech Laboratories FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2019
-59.78 INR
Jan 1, 2020
67.68 INR
Jan 1, 2021
108.00 INR
Jan 1, 2022
1,796.31 INR
Jan 1, 2023
-8.25 INR
Jan 1, 2024
-47.42 INR
Jan 1, 2025
-25.88 INR
Jan 1, 2026
-66.53 INR
The Zenotech Laboratories FCF Growth history
YEARFCF GrowthYoY
-66.53 %+157.11%
-25.88 %-45.42%
-47.42 %+474.89%
-8.25 %-100.46%
1,796.31 %+1,563.24%
108.00 %+59.58%
67.68 %-213.21%
-59.78 %-97.36%
-2,261.01 %-1,994.72%
119.33 %+213.08%
38.12 %-31.38%
55.55 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Year-over-Year Free Cash Flow Growth of Zenotech Laboratories is -66.53 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Zenotech Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories